Tarpeyo
NDC 81749-004, budesonide, capsule, delayed release, from Calliditas Therapeutics AB.
- Product NDC
- 81749-004
- Status
- Listed
- Labeler
- Calliditas Therapeutics AB
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215935
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81749-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE4 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81749-004-01 | 81749000401 | 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/938cada4-d6bf-4252-836f-dd40f9eadb4d
Use it
Look up 81749-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81749-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81749-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.